Dexelvucitabine
Dexelvucitabine is a failed experimental agent for the management of HIV infection. Dexelvucitabine is a cytidine nucleoside analog and nucleoside reverse transcriptase inhibitor. It was found to inhibit HIV-1 replication in vitro and during Phase II clinical trials, it was found to decrease mean viral load in patients with HIV.
* v
* t
* e
Link from a Wikipage to another Wikipage
primaryTopic
Dexelvucitabine
Dexelvucitabine is a failed experimental agent for the management of HIV infection. Dexelvucitabine is a cytidine nucleoside analog and nucleoside reverse transcriptase inhibitor. It was found to inhibit HIV-1 replication in vitro and during Phase II clinical trials, it was found to decrease mean viral load in patients with HIV.
* v
* t
* e
has abstract
Dexelvucitabine is a failed ex ...... phase II trial.
* v
* t
* e
@en
alternative name
Reverset
@en
IUPAC name
4-Amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-1-yl]pyrimidin-2(1H)-one
@en
Wikipage page ID
21.632.373
page length (characters) of wiki page
Wikipage revision ID
1.023.210.407
Link from a Wikipage to another Wikipage
ImageFile
@en
OtherNames
Reverset
@en
Verifiedfields
changed
@en
verifiedrevid
444.914.527
Watchedfields
changed
@en
wikiPageUsesTemplate
subject
hypernym
comment
Dexelvucitabine is a failed ex ...... ients with HIV.
* v
* t
* e
@en
label
Dexelvucitabine
@en